Alkermes
ALKS
275 hedge funds and large institutions have $4.67B invested in Alkermes in 2022 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 87 increasing their positions, 86 reducing their positions, and 24 closing their positions.
142% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 24
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
49% more call options, than puts
Call options by funds: $12.6M | Put options by funds: $8.46M
13% more capital invested
Capital invested by funds: $4.15B → $4.67B (+$520M)
11% more funds holding
Funds holding: 247 → 275 (+28)
1% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 86
2.07% less ownership
Funds ownership: 97.5% → 95.43% (-2.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$54.6M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
+$40M |
| 3 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$36.5M |
| 4 |
AC
Armistice Capital
New York
|
+$31.6M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$31.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$303M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$159M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$43M |
| 4 |
Morgan Stanley
New York
|
-$24.2M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$20.7M |
ALKS Hedge Fund Activity: Q2 2022 in Review
275 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Alkermes (ALKS) for Q2 2022, worth a combined $4.67B — up 13% from $4.15B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new ALKS positions and 24 closed out — a net gain of 34 holders — while 87 added to existing stakes and 86 trimmed.
The largest buyer was Lord, Abbett & Co, opening a new position worth an estimated $54.6M. The largest seller was T. Rowe Price Associates, cutting an estimated $303M.
- 275 institutional investors held Alkermes (ALKS) as of Q2 2022, up from 247 in Q1 2022.
- Funds reported $4.67B of Alkermes stock for Q2 2022, up 13% quarter-over-quarter.
- 58 funds opened new Alkermes positions in Q2 2022 and 24 closed out, a net change of +34 holders.
- The largest Alkermes buyer in Q2 2022 was Lord, Abbett & Co, an estimated $54.6M added.
- The largest Alkermes seller in Q2 2022 was T. Rowe Price Associates, an estimated $303M sold.
Based on aggregated 13F filings for Q2 2022.